NIH: Early antiretroviral benefits go beyond AIDS prevention
This article was originally published in Scrip
Executive Summary
Final results from the START study demonstrated there are a multitude of benefits with starting antiretroviral therapy early in HIV-infected patients that go beyond preventing AIDS and illnesses related to the disease, the National Institutes of Health (NIH) said on 20 July.